Investigating Mycoplasma Genitalium Infection and Resistance in HIV-infected Men in Hong Kong
Mycoplasma Genitalium Infection and Associated Antimicrobial Resistance Among HIV-infected Male in Hong Kong
This study is trying to find out how common Mycoplasma genitalium infections are and how resistant they are to treatment in men with HIV in Hong Kong.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 750 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong, Hong Kong, China) |
| Trial ID | NCT05789134 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence of Mycoplasma genitalium (MG) infection and its associated antimicrobial resistance patterns among HIV-infected males in Hong Kong. A total of 750 participants will be recruited from an HIV specialist clinic, where they will complete an online questionnaire and self-collect samples for testing. The study will utilize nucleic acid amplification tests to screen for MG, Chlamydia trachomatis, and Neisseria gonorrhoeae, as well as to detect resistance mutations. Clinical data will be gathered from medical records to provide a comprehensive understanding of co-infections and resistance patterns.
Who should consider this trial
Good fit: Ideal candidates for this study are HIV-infected males aged 18 or older who attend an HIV specialist clinic and can communicate in English or Chinese.
Not a fit: Patients who are not HIV-infected or unable to provide consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of MG infections and resistance in HIV-infected men, leading to improved treatment strategies.
How similar studies have performed: While studies on Mycoplasma genitalium have been conducted, this specific focus on HIV-infected males in Hong Kong may provide novel insights into antimicrobial resistance patterns.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * aged 18 or older, male, HIV-infected, and are attendees of the HIV specialist clinic, and can communicate in written and spoken English or Chinese Exclusion Criteria: * not able to provide consent
Where this trial is running
Hong Kong, Hong Kong, China
- The Chinese University of Hong Kong — Hong Kong, Hong Kong, China, Hong Kong (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.